Articles and posts

CEO Hanna Sjöström participates in this year’s Stanford Impact1 CEO Summit

CEO Hanna Sjöström participates in this year’s Stanford Impact1 CEO Summit

October 18, 2023 | News

BioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from Stanford

BioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from Stanford

October 16, 2023 | News

Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1

Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1

October 12, 2023 | News, Non regulatory

New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device

New successful results from clinical study on 100 newborn babies with Neola Medical’s medical device

October 10, 2023 | News, Non regulatory

Hanna Sjöström’s captivating investor presentation at the Redeye Medtech Seminar

Hanna Sjöström’s captivating investor presentation at the Redeye Medtech Seminar

September 28, 2023 | News, Presentations

CEO Hanna Sjöström comments Q2 report 2023 in new article by BioStock

CEO Hanna Sjöström comments Q2 report 2023 in new article by BioStock

August 17, 2023 | News

Neola Medical AB appoints ABG Sundal Collier as liquidity provider

Neola Medical AB appoints ABG Sundal Collier as liquidity provider

August 17, 2023 | News, Regulatory

CEO and CFO presents Q2 2023

CEO and CFO presents Q2 2023

August 16, 2023 | News, Presentations

Hör CEO Hanna Sjöström kommentera Q2-rapporten 2023 i Nyhetsbyrån Direkt

Hör CEO Hanna Sjöström kommentera Q2-rapporten 2023 i Nyhetsbyrån Direkt

August 15, 2023 | News, Presentations

Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.

Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.

August 15, 2023 | News, Regulatory

Neola Medicals trademark has been registered in the U.S.

Neola Medicals trademark has been registered in the U.S.

August 8, 2023 | News, Non regulatory

Neola Medical invites to presentation of the Q2-report 2023

Neola Medical invites to presentation of the Q2-report 2023

August 7, 2023 | News, Non regulatory

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in Neola Medical

Join our journey